Smart Drug Delivery System Market SWOT and PEST Analysis 2031
The Smart Drug Delivery System Market is expected to register a CAGR of 14.9% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented By Product (Connected Inhalers, Connected Autoinjectors, Connected Pen Injectors, Connected Wearable Injectors, Add-on Sensors, Others); Drug Delivery Mode (Injectable, Inhalation, Oral); Therapeutic Area (Metabolic Disorders, Neurological Disorders, Respiratory Disorders, Hormonal Disorders, Others); End User (Hospitals, Clinics, Home Care, Ambulatory Care Settings, Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Smart Drug Delivery System Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Smart Drug Delivery System Market Segmentation
Product- Connected Inhalers
- Connected Autoinjectors
- Connected Pen Injectors
- Connected Wearable Injectors
- Add-on Sensors
- Others
- Injectable
- Inhalation
- Oral
- Metabolic Disorders
- Neurological Disorders
- Respiratory Disorders
- Hormonal Disorders
- Others
- Hospitals
- Clinics
- Home Care
- Ambulatory Care Settings
- Others
- Hospitals
- Clinics
- Home Care
- Ambulatory Care Settings
- Others
Strategic Insights
Smart Drug Delivery System Market Growth Drivers- Advancements in Nanotechnology: To the great extent the use of nanotechnology has facilitated the emergence of smart drug delivery systems since it allows for drug release control at the cellular level. Localized therapy using Nano-carriers can be created thereby improving drug action while minimizing the side effects of drugs. There are various niches in cancer, the central nervous system and other related disorders where such precision in drug delivery is very advantageous, thus aiding in the expansion of the market.
- Growing Prevalence of Chronic Diseases: The rising prevalence of chronic disorders including diabetes, cardiovascular conditions, and cancer necessitates developing advanced drug delivery systems. Drug delivery systems are intelligent appliances that enhance disease management owing to their ability to control the release of drugs over a period of time. These devices ensure patient compliance to treatment and provide personalized treatment, hence their use in management of chronic conditions.
- Regulatory Support and Approvals: There is a growing approval of new therapies based on smart drug delivery systems by regulatory bodies such as the FDA and EMA due to their innovation potential. The increasing regulatory support ensures that the development of new products and taking them to the market is done at a shorter period than before, all of which lead to the faster uptake of these systems. This adjustment in regulations propels the growth of the smart drug delivery systems market.
- Integration of Artificial Intelligence and Machine Learning: The incorporation of artificial intelligence (AI) and machine learning (ML) in contemporary drug delivery systems is making it possible to come up with advanced and efficient treatments within shorter periods of time. It assists in understanding optimum drug release profile, likely patient behavior and enhances treatment accuracy. Drug advances can also focus on enhancing the existing therapies by faster AI systems improving the process of choosing the drugs.
- Focus on Biologics and Targeted Therapies: As the intake of biologics like monoclonal antibodies and gene therapy is increasing, it is also affecting the market of smart drug delivery systems. These regimes allow for the use of specific transport agents and systems that make such a treatment effective while controlling the treatment’s undesirable effects. In particular, the smart delivery systems for biologics improves the effectiveness of the treatment delivered to the patient and reduces the risk of adverse effects thus improving the patient outcomes.
- Development of Implantable and Wearable Devices: The emergence of implantable and wearable drug delivery devices seems to be the growing trend in the smart drug delivery market. These devices deliver medication on a constant and real-time basis, for instance for patients suffering from diabetes or to administer chemotherapeutic agents. Due to the technology that allows miniaturization, these systems are encumbered and enhance patients compliance thus offering an interventional approach unlike the conventional methods that adjust with time and volume delivery.
- Personalized Medicine Advancements: The advancement in the field of personalized medicine provides an impetus to the growth of smart drug delivery systems market. Individualized genotyping allows for treatment modification to enhance efficacy and reduce adverse reactions. Smart drug delivery systems allow for the controlled release of the drug at the right time, right dose and right place, which enhances the scope of personalized therapy improving patient benefits that drives the market demand.
- Expanding Applications in Oncology: Smart drug delivery systems exist in oncology, which allows for targeted therapies that lead to better treatment and lesser toxicity. Using these technologies with nanocarriers and responsive systems, patients can be treated with cancer drugs at the tumor site, avoiding the healthy tissues. With the shift in focus to more efficacious anticancer drug designs yet less invasive cancer treatments, the smart drug delivery market is poised to boom.
- Emerging Markets in Asia-Pacific: There exist more prospects for growth in the market for smart drug delivery systems in the Asia-Pacific region. The demand for advanced drug delivery systems is driven by the improvement of healthcare infrastructure, the rising incidence of chronic diseases, and increased spending on biotechnology. China and India are also embracing medical technologies, which is why the smart drug delivery systems market is likely to grow in those nations.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Smart Drug Delivery System Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Smart Drug Delivery System Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to grow at a CAGR of 14.9%
The North America region accounts for highest revenue share smart drug delivery systems market
Abbott Laboratories, Adherium Ltd., Amiko Digital Health Limited, Cognita Labs, Becton, Dickinson and Company, CeQur Corporation, BIOCORP, E3D Elcam Drug Delivery Devices, HCmed Innovations Co., Ltd., Medtronic plc, H&T Presspart Manufacturing Ltd., Novo Nordisk A/S are the some of the key market players operating in the smart drug delivery systems market
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)
Advancements in nanotechnology and growing prevalence of chronic diseases are the major factors boosting the smart drug delivery systems market growth
Table of Content
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Smart Drug Delivery System Market - By Product
1.3.2 Smart Drug Delivery System Market - By Drug Delivery Mode
1.3.3 Smart Drug Delivery System Market - By Therapeutic Area
1.3.4 Smart Drug Delivery System Market - By End User
1.3.5 Smart Drug Delivery System Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SMART DRUG DELIVERY SYSTEM MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SMART DRUG DELIVERY SYSTEM MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SMART DRUG DELIVERY SYSTEM MARKET - GLOBAL MARKET ANALYSIS
6.1. SMART DRUG DELIVERY SYSTEM - GLOBAL MARKET OVERVIEW
6.2. SMART DRUG DELIVERY SYSTEM - GLOBAL MARKET AND FORECAST TO 2030
6.3. MARKET POSITIONING
7. SMART DRUG DELIVERY SYSTEM MARKET - REVENUE AND FORECASTS TO 2030 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CONNECTED INHALERS
7.3.1. Overview
7.3.2. Connected Inhalers Market Forecast and Analysis
7.4. CONNECTED AUTOINJECTORS
7.4.1. Overview
7.4.2. Connected Autoinjectors Market Forecast and Analysis
7.5. CONNECTED PEN INJECTORS
7.5.1. Overview
7.5.2. Connected Pen Injectors Market Forecast and Analysis
7.6. CONNECTED WEARABLE INJECTORS
7.6.1. Overview
7.6.2. Connected Wearable Injectors Market Forecast and Analysis
7.7. ADD-ON SENSORS
7.7.1. Overview
7.7.2. Add-on Sensors Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. SMART DRUG DELIVERY SYSTEM MARKET - REVENUE AND FORECASTS TO 2030 - DRUG DELIVERY MODE
8.1. OVERVIEW
8.2. DRUG DELIVERY MODE MARKET FORECASTS AND ANALYSIS
8.3. INJECTABLE
8.3.1. Overview
8.3.2. Injectable Market Forecast and Analysis
8.4. INHALATION
8.4.1. Overview
8.4.2. Inhalation Market Forecast and Analysis
8.5. ORAL
8.5.1. Overview
8.5.2. Oral Market Forecast and Analysis
9. SMART DRUG DELIVERY SYSTEM MARKET - REVENUE AND FORECASTS TO 2030 - THERAPEUTIC AREA
9.1. OVERVIEW
9.2. THERAPEUTIC AREA MARKET FORECASTS AND ANALYSIS
9.3. METABOLIC DISORDERS
9.3.1. Overview
9.3.2. Metabolic Disorders Market Forecast and Analysis
9.4. NEUROLOGICAL DISORDERS
9.4.1. Overview
9.4.2. Neurological Disorders Market Forecast and Analysis
9.5. RESPIRATORY DISORDERS
9.5.1. Overview
9.5.2. Respiratory Disorders Market Forecast and Analysis
9.6. HORMONAL DISORDERS
9.6.1. Overview
9.6.2. Hormonal Disorders Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. SMART DRUG DELIVERY SYSTEM MARKET - REVENUE AND FORECASTS TO 2030 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. CLINICS
10.4.1. Overview
10.4.2. Clinics Market Forecast and Analysis
10.5. HOME CARE
10.5.1. Overview
10.5.2. Home Care Market Forecast and Analysis
10.6. AMBULATORY CARE SETTINGS
10.6.1. Overview
10.6.2. Ambulatory Care Settings Market Forecast and Analysis
10.7. OTHERS
10.7.1. Overview
10.7.2. Others Market Forecast and Analysis
11. SMART DRUG DELIVERY SYSTEM MARKET REVENUE AND FORECASTS TO 2030 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Smart Drug Delivery System Market Overview
11.1.2 North America Smart Drug Delivery System Market Forecasts and Analysis
11.1.3 North America Smart Drug Delivery System Market Forecasts and Analysis - By Product
11.1.4 North America Smart Drug Delivery System Market Forecasts and Analysis - By Drug Delivery Mode
11.1.5 North America Smart Drug Delivery System Market Forecasts and Analysis - By Therapeutic Area
11.1.6 North America Smart Drug Delivery System Market Forecasts and Analysis - By End User
11.1.7 North America Smart Drug Delivery System Market Forecasts and Analysis - By Countries
11.1.7.1 United States Smart Drug Delivery System Market
11.1.7.1.1 United States Smart Drug Delivery System Market by Product
11.1.7.1.2 United States Smart Drug Delivery System Market by Drug Delivery Mode
11.1.7.1.3 United States Smart Drug Delivery System Market by Therapeutic Area
11.1.7.1.4 United States Smart Drug Delivery System Market by End User
11.1.7.2 Canada Smart Drug Delivery System Market
11.1.7.2.1 Canada Smart Drug Delivery System Market by Product
11.1.7.2.2 Canada Smart Drug Delivery System Market by Drug Delivery Mode
11.1.7.2.3 Canada Smart Drug Delivery System Market by Therapeutic Area
11.1.7.2.4 Canada Smart Drug Delivery System Market by End User
11.1.7.3 Mexico Smart Drug Delivery System Market
11.1.7.3.1 Mexico Smart Drug Delivery System Market by Product
11.1.7.3.2 Mexico Smart Drug Delivery System Market by Drug Delivery Mode
11.1.7.3.3 Mexico Smart Drug Delivery System Market by Therapeutic Area
11.1.7.3.4 Mexico Smart Drug Delivery System Market by End User
11.2. EUROPE
11.2.1 Europe Smart Drug Delivery System Market Overview
11.2.2 Europe Smart Drug Delivery System Market Forecasts and Analysis
11.2.3 Europe Smart Drug Delivery System Market Forecasts and Analysis - By Product
11.2.4 Europe Smart Drug Delivery System Market Forecasts and Analysis - By Drug Delivery Mode
11.2.5 Europe Smart Drug Delivery System Market Forecasts and Analysis - By Therapeutic Area
11.2.6 Europe Smart Drug Delivery System Market Forecasts and Analysis - By End User
11.2.7 Europe Smart Drug Delivery System Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Smart Drug Delivery System Market
11.2.7.1.1 Germany Smart Drug Delivery System Market by Product
11.2.7.1.2 Germany Smart Drug Delivery System Market by Drug Delivery Mode
11.2.7.1.3 Germany Smart Drug Delivery System Market by Therapeutic Area
11.2.7.1.4 Germany Smart Drug Delivery System Market by End User
11.2.7.2 France Smart Drug Delivery System Market
11.2.7.2.1 France Smart Drug Delivery System Market by Product
11.2.7.2.2 France Smart Drug Delivery System Market by Drug Delivery Mode
11.2.7.2.3 France Smart Drug Delivery System Market by Therapeutic Area
11.2.7.2.4 France Smart Drug Delivery System Market by End User
11.2.7.3 Italy Smart Drug Delivery System Market
11.2.7.3.1 Italy Smart Drug Delivery System Market by Product
11.2.7.3.2 Italy Smart Drug Delivery System Market by Drug Delivery Mode
11.2.7.3.3 Italy Smart Drug Delivery System Market by Therapeutic Area
11.2.7.3.4 Italy Smart Drug Delivery System Market by End User
11.2.7.4 Spain Smart Drug Delivery System Market
11.2.7.4.1 Spain Smart Drug Delivery System Market by Product
11.2.7.4.2 Spain Smart Drug Delivery System Market by Drug Delivery Mode
11.2.7.4.3 Spain Smart Drug Delivery System Market by Therapeutic Area
11.2.7.4.4 Spain Smart Drug Delivery System Market by End User
11.2.7.5 United Kingdom Smart Drug Delivery System Market
11.2.7.5.1 United Kingdom Smart Drug Delivery System Market by Product
11.2.7.5.2 United Kingdom Smart Drug Delivery System Market by Drug Delivery Mode
11.2.7.5.3 United Kingdom Smart Drug Delivery System Market by Therapeutic Area
11.2.7.5.4 United Kingdom Smart Drug Delivery System Market by End User
11.2.7.6 Rest of Europe Smart Drug Delivery System Market
11.2.7.6.1 Rest of Europe Smart Drug Delivery System Market by Product
11.2.7.6.2 Rest of Europe Smart Drug Delivery System Market by Drug Delivery Mode
11.2.7.6.3 Rest of Europe Smart Drug Delivery System Market by Therapeutic Area
11.2.7.6.4 Rest of Europe Smart Drug Delivery System Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Smart Drug Delivery System Market Overview
11.3.2 Asia-Pacific Smart Drug Delivery System Market Forecasts and Analysis
11.3.3 Asia-Pacific Smart Drug Delivery System Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Smart Drug Delivery System Market Forecasts and Analysis - By Drug Delivery Mode
11.3.5 Asia-Pacific Smart Drug Delivery System Market Forecasts and Analysis - By Therapeutic Area
11.3.6 Asia-Pacific Smart Drug Delivery System Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Smart Drug Delivery System Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Smart Drug Delivery System Market
11.3.7.1.1 Australia Smart Drug Delivery System Market by Product
11.3.7.1.2 Australia Smart Drug Delivery System Market by Drug Delivery Mode
11.3.7.1.3 Australia Smart Drug Delivery System Market by Therapeutic Area
11.3.7.1.4 Australia Smart Drug Delivery System Market by End User
11.3.7.2 China Smart Drug Delivery System Market
11.3.7.2.1 China Smart Drug Delivery System Market by Product
11.3.7.2.2 China Smart Drug Delivery System Market by Drug Delivery Mode
11.3.7.2.3 China Smart Drug Delivery System Market by Therapeutic Area
11.3.7.2.4 China Smart Drug Delivery System Market by End User
11.3.7.3 India Smart Drug Delivery System Market
11.3.7.3.1 India Smart Drug Delivery System Market by Product
11.3.7.3.2 India Smart Drug Delivery System Market by Drug Delivery Mode
11.3.7.3.3 India Smart Drug Delivery System Market by Therapeutic Area
11.3.7.3.4 India Smart Drug Delivery System Market by End User
11.3.7.4 Japan Smart Drug Delivery System Market
11.3.7.4.1 Japan Smart Drug Delivery System Market by Product
11.3.7.4.2 Japan Smart Drug Delivery System Market by Drug Delivery Mode
11.3.7.4.3 Japan Smart Drug Delivery System Market by Therapeutic Area
11.3.7.4.4 Japan Smart Drug Delivery System Market by End User
11.3.7.5 South Korea Smart Drug Delivery System Market
11.3.7.5.1 South Korea Smart Drug Delivery System Market by Product
11.3.7.5.2 South Korea Smart Drug Delivery System Market by Drug Delivery Mode
11.3.7.5.3 South Korea Smart Drug Delivery System Market by Therapeutic Area
11.3.7.5.4 South Korea Smart Drug Delivery System Market by End User
11.3.7.6 Rest of Asia-Pacific Smart Drug Delivery System Market
11.3.7.6.1 Rest of Asia-Pacific Smart Drug Delivery System Market by Product
11.3.7.6.2 Rest of Asia-Pacific Smart Drug Delivery System Market by Drug Delivery Mode
11.3.7.6.3 Rest of Asia-Pacific Smart Drug Delivery System Market by Therapeutic Area
11.3.7.6.4 Rest of Asia-Pacific Smart Drug Delivery System Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Smart Drug Delivery System Market Overview
11.4.2 Middle East and Africa Smart Drug Delivery System Market Forecasts and Analysis
11.4.3 Middle East and Africa Smart Drug Delivery System Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Smart Drug Delivery System Market Forecasts and Analysis - By Drug Delivery Mode
11.4.5 Middle East and Africa Smart Drug Delivery System Market Forecasts and Analysis - By Therapeutic Area
11.4.6 Middle East and Africa Smart Drug Delivery System Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Smart Drug Delivery System Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Smart Drug Delivery System Market
11.4.7.1.1 South Africa Smart Drug Delivery System Market by Product
11.4.7.1.2 South Africa Smart Drug Delivery System Market by Drug Delivery Mode
11.4.7.1.3 South Africa Smart Drug Delivery System Market by Therapeutic Area
11.4.7.1.4 South Africa Smart Drug Delivery System Market by End User
11.4.7.2 Saudi Arabia Smart Drug Delivery System Market
11.4.7.2.1 Saudi Arabia Smart Drug Delivery System Market by Product
11.4.7.2.2 Saudi Arabia Smart Drug Delivery System Market by Drug Delivery Mode
11.4.7.2.3 Saudi Arabia Smart Drug Delivery System Market by Therapeutic Area
11.4.7.2.4 Saudi Arabia Smart Drug Delivery System Market by End User
11.4.7.3 U.A.E Smart Drug Delivery System Market
11.4.7.3.1 U.A.E Smart Drug Delivery System Market by Product
11.4.7.3.2 U.A.E Smart Drug Delivery System Market by Drug Delivery Mode
11.4.7.3.3 U.A.E Smart Drug Delivery System Market by Therapeutic Area
11.4.7.3.4 U.A.E Smart Drug Delivery System Market by End User
11.4.7.4 Rest of Middle East and Africa Smart Drug Delivery System Market
11.4.7.4.1 Rest of Middle East and Africa Smart Drug Delivery System Market by Product
11.4.7.4.2 Rest of Middle East and Africa Smart Drug Delivery System Market by Drug Delivery Mode
11.4.7.4.3 Rest of Middle East and Africa Smart Drug Delivery System Market by Therapeutic Area
11.4.7.4.4 Rest of Middle East and Africa Smart Drug Delivery System Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Smart Drug Delivery System Market Overview
11.5.2 South and Central America Smart Drug Delivery System Market Forecasts and Analysis
11.5.3 South and Central America Smart Drug Delivery System Market Forecasts and Analysis - By Product
11.5.4 South and Central America Smart Drug Delivery System Market Forecasts and Analysis - By Drug Delivery Mode
11.5.5 South and Central America Smart Drug Delivery System Market Forecasts and Analysis - By Therapeutic Area
11.5.6 South and Central America Smart Drug Delivery System Market Forecasts and Analysis - By End User
11.5.7 South and Central America Smart Drug Delivery System Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Smart Drug Delivery System Market
11.5.7.1.1 Brazil Smart Drug Delivery System Market by Product
11.5.7.1.2 Brazil Smart Drug Delivery System Market by Drug Delivery Mode
11.5.7.1.3 Brazil Smart Drug Delivery System Market by Therapeutic Area
11.5.7.1.4 Brazil Smart Drug Delivery System Market by End User
11.5.7.2 Argentina Smart Drug Delivery System Market
11.5.7.2.1 Argentina Smart Drug Delivery System Market by Product
11.5.7.2.2 Argentina Smart Drug Delivery System Market by Drug Delivery Mode
11.5.7.2.3 Argentina Smart Drug Delivery System Market by Therapeutic Area
11.5.7.2.4 Argentina Smart Drug Delivery System Market by End User
11.5.7.3 Rest of South and Central America Smart Drug Delivery System Market
11.5.7.3.1 Rest of South and Central America Smart Drug Delivery System Market by Product
11.5.7.3.2 Rest of South and Central America Smart Drug Delivery System Market by Drug Delivery Mode
11.5.7.3.3 Rest of South and Central America Smart Drug Delivery System Market by Therapeutic Area
11.5.7.3.4 Rest of South and Central America Smart Drug Delivery System Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SMART DRUG DELIVERY SYSTEM MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. SMART DRUG DELIVERY SYSTEM MARKET, KEY COMPANY PROFILES
14.1. ABBOTT LABORATORIES
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ADHERIUM LTD.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. AMIKO DIGITAL HEALTH LIMITED
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BECTON, DICKINSON AND COMPANY
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BIOCORP
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. CEQUR CORPORATION
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. COGNITA LABS
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. E3D ELCAM DRUG DELIVERY DEVICES
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. MEDTRONIC PLC
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. NOVO NORDISK A/S
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
1. ABBOTT LABORATORIES
2. ADHERIUM LTD.
3. AMIKO DIGITAL HEALTH LIMITED
4. BECTON, DICKINSON AND COMPANY
5. BIOCORP
6. CEQUR CORPORATION
7. COGNITA LABS
8. HCMED INNOVATIONS CO., LTD.
9. MEDTRONIC PLC
10. NOVO NORDISK A/S
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For